Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 84 (4) , 546-556
- https://doi.org/10.1016/0091-6749(89)90369-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Experience with daily immunotherapy in 59 adult allergic patientsJournal of Allergy and Clinical Immunology, 1982
- Failure of hyposensitisation in treatment of children with grass-pollen asthma.BMJ, 1982
- Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two stepsJournal of Allergy and Clinical Immunology, 1981
- Measurement of ‘Blocking Antibodies’ to Pollen Antigens by Radiolabelled Protein A from Staphylococcus aureusInternational Archives of Allergy and Immunology, 1981
- Immunotherapy in Hay Fever with Two Major Allergens 19, 25 and Partially Purified Extract of Timothy Grass PollenAllergy, 1980
- Polymerized whole ragweed: Human safety and immune responseJournal of Allergy and Clinical Immunology, 1980
- Clinical Studies of a Purified Timothy Pollen ExtractInternational Archives of Allergy and Immunology, 1980
- Reduced allergenicity of high molecular weight ragweed polymersJournal of Allergy and Clinical Immunology, 1979
- The role of ragweed pollen in autumnal asthmaJournal of Allergy and Clinical Immunology, 1977
- Comparison of Polymerized and Unpolymerized Antigen E for Immunotherapy of Ragweed AllergyNew England Journal of Medicine, 1976